Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

En studie for å lære om studiemedisinen kalt Elranatamab hos personer med multippelt myelom (MM) som har kommet tilbake etter å ha tatt andre behandlinger (inkludert tidligere behandling med et anti-CD38-antistoff og lenalidomid)

10. november 2026 oppdatert av: Pfizer

En fase 3, åpen studie av Elranatamab monoterapi versus Elotuzumab, pomalidomid, deksametason (EPd) eller pomalidomid, bortezomib, deksametason (PVd) eller karfilzomib, deksametason (Kd) hos deltakere med tilbakefallende/refraktorer mot 38-refraktorer som har fått tilbakefall/refraktor. Regissert terapi (MagnetisMM-32)

The purpose of this study is to learn about the study medicine called elranatamab.This study aims to compare elranatamab to other medicines for the treatment of MM (a type of cancer).

This study is seeking participants who:

  • Are 18 years of age or older and have MM.
  • Have received treatments before for MM.
  • Have MM that has returned or not responded to their most recent treatment.

Half of the participants will receive elranatamab. The other half of participants will receive a combination therapy selected by the study doctor. The selected combination therapy will include 2 to 3 different medicines commonly used to treat MM.

Elranatamab will be given as a shot under the skin at the study clinic about once a week. This may change to a smaller number of shots later in the study.

The medicines in the combination therapy will be taken by mouth (at home or at the study clinic) AND will be given either as:

  • a shot under the skin at the study clinic
  • through a needle in the vein at the study clinic The number of times these medicines will be taken depends on what combination therapy the study doctor selects.

Participants may continue to receive elranatamab or a combination therapy until their MM is no longer responding. The study team will see how each participant is doing with the study treatment during regular visits at the study clinic. The study team will continue to follow-up with participants after study treatment with telephone contacts (or visits).

The study will compare the experiences of people receiving elranatamab to those people receiving a combination therapy. This will help learn about the safety and how effective elranatamab is.

Studieoversikt

Status

Rekruttering

Forhold

Intervensjon / Behandling

Studietype

Intervensjonell

Registrering (Antatt)

492

Fase

  • Fase 3

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studiesteder

      • La Plata, Argentina, 1900
        • Rekruttering
        • Hospital Italiano de La Plata
    • Buenos Aires
      • Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina, C1426ANZ
        • Rekruttering
        • Instituto Alexander Fleming
      • Pilar, Buenos Aires, Argentina, 1629
        • Rekruttering
        • Hospital Universitario Austral
    • Buenos Aires F.D.
      • Ciudad de Buenos Aires, Buenos Aires F.D., Argentina, C1199ABB
        • Rekruttering
        • Hospital Italiano de Buenos Aires
    • New South Wales
      • Blacktown, New South Wales, Australia, 2148
        • Rekruttering
        • Blacktown Hospital
      • Concord, New South Wales, Australia, 2139
        • Rekruttering
        • Concord Repatriation General Hospital
    • Queensland
      • Birtinya, Queensland, Australia, 4575
        • Rekruttering
        • Sunshine Coast University Hospital
      • Brisbane, Queensland, Australia, 4029
        • Rekruttering
        • Royal Brisbane and Women's Hospital
    • Victoria
      • Fitzroy, Victoria, Australia, 3065
        • Rekruttering
        • St Vincent's Hospital (Melbourne)
      • Geelong, Victoria, Australia, 3220
        • Rekruttering
        • Barwon Health
    • Western Australia
      • Nedlands, Western Australia, Australia, 6009
        • Rekruttering
        • Sir Charles Gairdner Hospital, Haematology Clinical Trials
    • Bruxelles-capitale, Région de
      • Brussels, Bruxelles-capitale, Région de, Belgia, 1090
        • Rekruttering
        • UZ Brussel
    • Hainaut
      • Gilly, Hainaut, Belgia, 6060
        • Rekruttering
        • Grand Hôpital de Charleroi
      • Hornu, Hainaut, Belgia, 7301
        • Rekruttering
        • Centre Hospitalier Epicura
    • Liège
      • Verviers, Liège, Belgia, 4800
        • Rekruttering
        • CHR Verviers - La Tourelle
    • Namur
      • Yvoir, Namur, Belgia, 5530
        • Rekruttering
        • Université Catholique de Louvain-Namur - Centre Hospitalier Universitaire Dinant-Godinne - Site Godi
      • Rio de Janeiro, Brasil, 22775001
        • Rekruttering
        • Americas Centro de Oncologia Integrado
      • Rio de Janeiro, Brasil, 20775-001
        • Rekruttering
        • Instituto de Educação, Pesquisa e Gestão em Saúde
      • Rio de Janeiro, Brasil, 22793-080
        • Rekruttering
        • Instituto de Educação, Pesquisa e Gestão em Saúde
      • São Paulo, Brasil, 01232-010
        • Rekruttering
        • ESHO Empresa de Serviços Hospitalares S.A/ Hospital Samaritano de Higienópolis
      • São Paulo, Brasil, 04537-080
        • Rekruttering
        • Clínica Médica São Germano S/S Ltda
      • São Paulo, Brasil, 04024-002
        • Rekruttering
        • Universidade Federal de Sao Paulo
      • São Paulo, Brasil, 04024-002
        • Rekruttering
        • HU UNIFESP / SPDM - Hospital São Paulo
      • São Paulo, Brasil, 01401-002
        • Rekruttering
        • Instituto D'Or de Pesquisa e Ensino (IDOR)
    • Estado de Bahia
      • Salvador, Estado de Bahia, Brasil, 41253-190
        • Rekruttering
        • Instituto D'Or de Pesquisa e Ensino (IDOR) - Filial Salvador
    • Rio Grande do Sul
      • Porto Alegre, Rio Grande do Sul, Brasil, 90850-170
        • Rekruttering
        • Centro de Pesquisa Clínica - Área Administrativa
      • Porto Alegre, Rio Grande do Sul, Brasil, 90880-480
        • Rekruttering
        • Hospital Mae de Deus
      • Porto Alegre, Rio Grande do Sul, Brasil, 90035-001
        • Rekruttering
        • Hospital Moinhos de Vento
      • Porto Alegre, Rio Grande do Sul, Brasil, 90110-270
        • Rekruttering
        • Centro Gaucho Integrado De Oncologia, Hematologia, Ensino E Pesquisa
    • Rio de Janeiro
      • Niterói, Rio de Janeiro, Brasil, 24220-070
        • Rekruttering
        • Instituto Oncomed de Educação e Pesquisa
      • Niterói, Rio de Janeiro, Brasil, 24220-300
        • Rekruttering
        • Oncomed Clínica Oncológica
    • São Paulo
      • Jaú, São Paulo, Brasil, 17210-080
        • Rekruttering
        • Hospital Amaral Carvalho
      • Ribeirão Preto, São Paulo, Brasil, 14051-140
        • Rekruttering
        • Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (USP)
      • SP, São Paulo, Brasil, 04537-080
        • Rekruttering
        • Clínica Médica São Germano LTDA
      • São Paulo, São Paulo, Brasil, 04543-000
        • Rekruttering
        • Instituto D'Or de Pesquisa e Ensino (IDOR)
    • New Brunswick
      • Moncton, New Brunswick, Canada, E1C 6Z8
        • Rekruttering
        • The Moncton Hospital
    • Quebec
      • Montreal, Quebec, Canada, H3T 1E2
        • Rekruttering
        • Jewish General Hospital
      • Montreal, Quebec, Canada, H4J 1C5
        • Rekruttering
        • l'Hôpital du Sacré-Cœur-de-Montréal
    • Santiago Metropolitan
      • Providencia, Santiago Metropolitan, Chile, 7500836
        • Rekruttering
        • FALP
      • Providencia, Santiago Metropolitan, Chile, 7500966
        • Rekruttering
        • FALP
      • Santiago, Santiago Metropolitan, Chile, 7580206
        • Rekruttering
        • Clínica Inmunocel
      • Santiago, Santiago Metropolitan, Chile, 7500921
        • Rekruttering
        • FALP
      • Santiago, Santiago Metropolitan, Chile, 7620157
        • Rekruttering
        • Clínica Universidad de Los Andes
      • Santiago, Santiago Metropolitan, Chile, 7650568
        • Rekruttering
        • Clínica Alemana de Santiago
      • Copenhagen Ø, Danmark, DK 2100
        • Rekruttering
        • Rigshospitalet
    • Central Jutland
      • Aarhus, Central Jutland, Danmark, 8200
        • Rekruttering
        • Aarhus Universitetshospital, Skejby
    • North Denmark
      • Aalborg, North Denmark, Danmark, 9000
        • Rekruttering
        • Aalborg Universitetshospital, Syd
      • Oulu, Finland, 90220
        • Aktiv, ikke rekrutterende
        • Oulun yliopistollinen sairaala
    • Southwest Finland
      • Turku, Southwest Finland, Finland, 20520
        • Aktiv, ikke rekrutterende
        • Turku University Hospital
    • Uusimaa
      • Helsinki, Uusimaa, Finland, 00029
        • Aktiv, ikke rekrutterende
        • Helsinki University Hospital - Comprehensive Cancer Center (HYKS - Syöpäkeskus)
    • Alabama
      • Mobile, Alabama, Forente stater, 36607
        • Rekruttering
        • Infirmary Cancer Care
    • California
      • Beverly Hills, California, Forente stater, 90211
        • Rekruttering
        • Beverly Hills Cancer Center
      • Clovis, California, Forente stater, 93611
        • Rekruttering
        • Community Cancer Institute
      • Clovis, California, Forente stater, 93611
        • Rekruttering
        • Clovis Community Medical Center
      • Encino, California, Forente stater, 91316
        • Rekruttering
        • Clinical Research Advisors (Encino Satellite Location)
      • Fresno, California, Forente stater, 93701
        • Rekruttering
        • University of California San Francisco
      • Fresno, California, Forente stater, 93721
        • Rekruttering
        • Community Regional Medical Center
      • Irvine, California, Forente stater, 92618
        • Aktiv, ikke rekrutterende
        • Hoag Health Center Irvine
      • Irvine, California, Forente stater, 92618
        • Aktiv, ikke rekrutterende
        • Hoag Hospital Irvine
      • Los Angeles, California, Forente stater, 90067
        • Rekruttering
        • Valkyrie Clinical Trials
      • Los Angeles, California, Forente stater, 90020
        • Rekruttering
        • Clinical Research Advisors (Korea Town Satellite Location)
      • Los Angeles, California, Forente stater, 90048
        • Rekruttering
        • Clinical Research Advisors (West Hollywood Satellite Location)
      • Newport Beach, California, Forente stater, 92663
        • Aktiv, ikke rekrutterende
        • Hoag Memorial Hospital Presbyterian
      • Panorama City, California, Forente stater, 91402
        • Rekruttering
        • Mission Community Hospital (Satellite Site)
      • Sacramento, California, Forente stater, 95817
        • Rekruttering
        • University of California Davis (UC Davis) Comprehensive Cancer Center
      • Sacramento, California, Forente stater, 95817
        • Rekruttering
        • University of California
    • Colorado
      • Fort Collins, Colorado, Forente stater, 80524
        • Rekruttering
        • UCHealth Poudre Valley Hospital
      • Fort Collins, Colorado, Forente stater, 80528
        • Rekruttering
        • UCHealth Harmony
      • Greeley, Colorado, Forente stater, 80634
        • Rekruttering
        • UCHealth Greeley Hospital
      • Longmont, Colorado, Forente stater, 80504
        • Rekruttering
        • UCHealth Longs Peak Hospital
      • Longmont, Colorado, Forente stater, 80504
        • Rekruttering
        • UCHealth Longs Peak Medical Center
      • Loveland, Colorado, Forente stater, 80538
        • Rekruttering
        • UCHealth - Medical Center of the Rockies
    • Florida
      • Coral Gables, Florida, Forente stater, 33146
        • Rekruttering
        • Sylvester Comprehensive Cancer Center - The Lennar Foundation Medical Center
      • Deerfield Beach, Florida, Forente stater, 33442
        • Rekruttering
        • University of Miami Hospital and Clinics - Deerfield Beach
      • Doral, Florida, Forente stater, 33166
        • Rekruttering
        • Sylvester Comprehensive Cancer Center- Doral
      • Hollywood, Florida, Forente stater, 33021
        • Rekruttering
        • Sylvester Comprehensive Cancer Center - Hollywood
      • Miami, Florida, Forente stater, 33136
        • Rekruttering
        • Sylvester Comprehensive Cancer Center
      • Miami, Florida, Forente stater, 33176
        • Rekruttering
        • Baptist Hospital of Miami
      • Miami, Florida, Forente stater, 33176
        • Rekruttering
        • Miami Cancer Institute at Baptist Health, Inc.
      • Miami, Florida, Forente stater, 33136
        • Rekruttering
        • University of Miami Hospital and Clinics
      • Miami, Florida, Forente stater, 33136
        • Rekruttering
        • University of Miami Hospital and Clinics - Griffin Cancer Research Building
      • Miami, Florida, Forente stater, 33176
        • Rekruttering
        • Sylvester Comprehensive Cancer Center- Kendall
      • Plantation, Florida, Forente stater, 33322
        • Rekruttering
        • BRCR Global
      • Plantation, Florida, Forente stater, 33322
        • Rekruttering
        • Brcr Medical Center, Inc.
      • Plantation, Florida, Forente stater, 33322
        • Rekruttering
        • BRCR Medical Center Inc
      • Plantation, Florida, Forente stater, 33324
        • Rekruttering
        • HCA Florida Westside Hospital
      • Tamarac, Florida, Forente stater, 33321
        • Rekruttering
        • BRCR Medical Center Inc.
    • Illinois
      • Chicago, Illinois, Forente stater, 60625
        • Rekruttering
        • Endeavor Health - Swedish Hospital
      • Evanston, Illinois, Forente stater, 60201
        • Rekruttering
        • Endeavor Health - Evanston Hospital
      • Glenview, Illinois, Forente stater, 60026
        • Rekruttering
        • Endeavor Health - Glenbrook Hospital Ambulatory Care Center
      • Highland Park, Illinois, Forente stater, 60035
        • Rekruttering
        • Endeavor Health - Highland Park Hospital Health Center 1
      • Springfield, Illinois, Forente stater, 62781
        • Rekruttering
        • Springfield Memorial Hospital
      • Springfield, Illinois, Forente stater, 62702
        • Rekruttering
        • Simmons Cancer Institute at SIU
      • Springfield, Illinois, Forente stater, 62703
        • Rekruttering
        • Springfield Clinic Main Campus
      • Springfield, Illinois, Forente stater, 62769
        • Rekruttering
        • HSHS St. John's Hospital
      • Zion, Illinois, Forente stater, 60099
        • Rekruttering
        • Midwestern Regional Medical Center, Inc. dba City of Hope Chicago
    • Indiana
      • Indianapolis, Indiana, Forente stater, 46250
        • Rekruttering
        • Community Health Network, Inc.
      • Indianapolis, Indiana, Forente stater, 46227
        • Rekruttering
        • Community Health Network, Inc.
      • Indianapolis, Indiana, Forente stater, 46256
        • Rekruttering
        • Community Health Network, Inc.
    • Kansas
      • Kansas City, Kansas, Forente stater, 66112
        • Rekruttering
        • American Oncology Partners, P.A. Dba MidAmerica Cancer Care
      • Leawood, Kansas, Forente stater, 66211
        • Rekruttering
        • Ascentist Doctors' Hospital
      • Merriam, Kansas, Forente stater, 66204
        • Rekruttering
        • American Oncology Partners, P.A. Dba MidAmerica Cancer Care
    • Massachusetts
      • Boston, Massachusetts, Forente stater, 02215
        • Rekruttering
        • Beth Israel Deaconess Medical Center
      • Boston, Massachusetts, Forente stater, 02215
        • Rekruttering
        • BIDMC Research Pharmacy
    • Missouri
      • Belton, Missouri, Forente stater, 64012
        • Rekruttering
        • American Oncology Partners, P.A. Dba MidAmerica Cancer Care
      • Independence, Missouri, Forente stater, 64057
        • Rekruttering
        • MIVA Medical
      • Kansas City, Missouri, Forente stater, 64128
        • Rekruttering
        • Kansas City VA Medical Center
      • Kansas City, Missouri, Forente stater, 64132
        • Rekruttering
        • American Oncology Partners, P.A. Dba MidAmerica Cancer Care
    • Nebraska
      • Lincoln, Nebraska, Forente stater, 68506
        • Rekruttering
        • Bryan Medical Center
      • Lincoln, Nebraska, Forente stater, 68506
        • Rekruttering
        • NHO Revive Research Institute, LLC
    • New York
      • Hawthorne, New York, Forente stater, 10532
        • Aktiv, ikke rekrutterende
        • WMCHealth Advanced Physician Services
      • Lake Success, New York, Forente stater, 11042
        • Rekruttering
        • Northwell Health/ RJ Zuckerberg Cancer Center
      • Manhasset, New York, Forente stater, 11030
        • Rekruttering
        • North Shore University Hospital
      • New Hyde Park, New York, Forente stater, 11040
        • Rekruttering
        • Long Island Jewish Medical Center
      • Valhalla, New York, Forente stater, 10595
        • Aktiv, ikke rekrutterende
        • Westchester Medical Center
    • North Dakota
      • Fargo, North Dakota, Forente stater, 58102
        • Rekruttering
        • Sanford Fargo Medical Center
    • Ohio
      • Cincinnati, Ohio, Forente stater, 45236
        • Rekruttering
        • The Jewish Hospital
      • Cincinnati, Ohio, Forente stater, 45245
        • Rekruttering
        • Oncology Hematology Care Clinical Trials, LLC
      • Cincinnati, Ohio, Forente stater, 45220
        • Rekruttering
        • TriHealth Cancer Institute-Good Samaritan Hospital
      • Cincinnati, Ohio, Forente stater, 45242
        • Rekruttering
        • Oncology Hematology Care Clinical Trials, LLC
      • Cincinnati, Ohio, Forente stater, 45242
        • Rekruttering
        • TriHealth Cancer Institute- Thomas Comprehensive Care Center
      • Cincinnati, Ohio, Forente stater, 45211
        • Rekruttering
        • Oncology Hematology Care Clinical Trials, LLC
      • Cincinnati, Ohio, Forente stater, 45236
        • Rekruttering
        • Oncology Hematology Care Clinical Trials, LLC
      • Cleveland, Ohio, Forente stater, 44195
        • Rekruttering
        • Cleveland Clinic
    • Pennsylvania
      • Pittsburgh, Pennsylvania, Forente stater, 15224
        • Rekruttering
        • AHN West Penn Hospital
    • Rhode Island
      • Providence, Rhode Island, Forente stater, 02906
        • Rekruttering
        • The Miriam Hospital
      • Providence, Rhode Island, Forente stater, 02903
        • Rekruttering
        • Rodhe Island Hospital
    • South Carolina
      • Greenville, South Carolina, Forente stater, 29607
        • Aktiv, ikke rekrutterende
        • St Francis Cancer Center
    • Tennessee
      • Nashville, Tennessee, Forente stater, 37203
        • Rekruttering
        • Ascension St. Thomas Hospital
      • Nashville, Tennessee, Forente stater, 37203
        • Rekruttering
        • Tennessee Oncology, PLLC - Investigational Drug Services
      • Nashville, Tennessee, Forente stater, 37203
        • Rekruttering
        • Tennessee Oncology, PLLC - Nashville Elliston Place Plaza Center for Blood Cancers
      • Nashville, Tennessee, Forente stater, 37203
        • Rekruttering
        • Tennessee Oncology, PLLC - Nashville Elliston Place Plaza DDU
      • Nashville, Tennessee, Forente stater, 37203
        • Rekruttering
        • Tennessee Oncology, PLLC - Nashville Elliston Place Plaza Medical Oncology & Hematology
    • Texas
      • Dallas, Texas, Forente stater, 75246
        • Rekruttering
        • Baylor University Medical Center
      • Dallas, Texas, Forente stater, 75246
        • Rekruttering
        • Baylor University Medical Center, Investigational Drug Services, Department of Pharmacy
      • Houston, Texas, Forente stater, 77094
        • Rekruttering
        • Houston Methodist West Hospital
      • Houston, Texas, Forente stater, 77070
        • Rekruttering
        • Houston Methodist Willowbrook Hospital
      • Houston, Texas, Forente stater, 77030
        • Rekruttering
        • Houston Methodist Hospital Cancer Center
      • Houston, Texas, Forente stater, 77030
        • Rekruttering
        • Houston Methodist Cancer Center Infusion
      • Houston, Texas, Forente stater, 77030
        • Rekruttering
        • Houston Methodist Hospital - Department of Pharmacy
      • Houston, Texas, Forente stater, 77058
        • Rekruttering
        • Houston Methodist Clear Lake Hospital (St. John)
      • Lubbock, Texas, Forente stater, 79410
        • Rekruttering
        • Joe Arrington Cancer Research and Treatment Center
      • Sugar Land, Texas, Forente stater, 77479
        • Rekruttering
        • Houston Methodist Sugar Land Hospital
      • Temple, Texas, Forente stater, 76508
        • Rekruttering
        • Baylor Scott & White Medical Center - Temple
      • The Woodlands, Texas, Forente stater, 77385
        • Rekruttering
        • Houston Methodist The Woodlands Hospital
    • West Virginia
      • Morgantown, West Virginia, Forente stater, 26506
        • Rekruttering
        • WVU Cancer Institute
    • Wisconsin
      • Madison, Wisconsin, Forente stater, 53718
        • Rekruttering
        • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center
      • Madison, Wisconsin, Forente stater, 53792
        • Rekruttering
        • University of Wisconsin Carbone Cancer Center-University Hospital
      • Bayonne, Frankrike, 64109
        • Rekruttering
        • Centre Hospitalier de la Côte Basque
      • La Roche-sur-Yon, Frankrike, 85925
        • Rekruttering
        • CHD Vendee
      • Le Mans, Frankrike, 72037
        • Rekruttering
        • Centre Hospitalier du Mans
      • Paris, Frankrike, 75015
        • Rekruttering
        • Hôpital Universitaire Necker Enfants Malades
      • Paris, Frankrike, 75679
        • Rekruttering
        • Hopitaux Universitaires Paris Centre-Hopital Cochin
      • Quimper, Frankrike, 29107
        • Rekruttering
        • Centre Hospitalier de Cornouaille
      • Tours, Frankrike, 37044
        • Rekruttering
        • Centre Hospitalier Régional Universitaire de Tours - Hôpital Bretonneau
      • Vannes, Frankrike, 56000
        • Aktiv, ikke rekrutterende
        • Centre Hospitalier Bretagne Atlantique
      • Vannes, Frankrike, 56017
        • Aktiv, ikke rekrutterende
        • Centre Hospitalier Bretagne Atlantique
    • Aquitaine
      • Pessac, Aquitaine, Frankrike, 33600
        • Rekruttering
        • CHU Bordeaux Haut-Leveque
    • Haute-garonne
      • Toulouse, Haute-garonne, Frankrike, 31100
        • Rekruttering
        • Institut Universitaire du Cancer Toulouse - Oncopole - CHU de TOULOUSE
    • Pays de la Loire Region
      • Nantes, Pays de la Loire Region, Frankrike, 44000
        • Rekruttering
        • Centre Hospitalier Universitaire de Nantes - L' Hopital l'hôtel-Dieu
    • Val-d'oise
      • Pontoise, Val-d'oise, Frankrike, 95300
        • Rekruttering
        • Hôpital NOVO
    • Val-de-marne
      • Créteil, Val-de-marne, Frankrike, 94010
        • Rekruttering
        • Henri Mondor Hospital
    • Vienne
      • City/Town/Village, Vienne, Frankrike, 86021
        • Rekruttering
        • Centre Hospitalier Universitaire de Poitiers
    • Anatolikí Makedonía KAI Thráki
      • Alexandroupoli, Anatolikí Makedonía KAI Thráki, Hellas, 681 00
        • Aktiv, ikke rekrutterende
        • University General Hospital of Alexandroupoli
    • Attikí
      • Athens, Attikí, Hellas, 115 28
        • Aktiv, ikke rekrutterende
        • Alexandra General Hospital of Athens
    • Kentrikí Makedonía
      • Thessaloniki, Kentrikí Makedonía, Hellas, 54639
        • Aktiv, ikke rekrutterende
        • "Theagenio" Cancer Hospital of Thessaloniki
    • Thessaloníki
      • Thessaloniki, Thessaloníki, Hellas, 570 10
        • Aktiv, ikke rekrutterende
        • G. Papanikolaou General Hospital
    • Ípeiros
      • Ioannina, Ípeiros, Hellas, 455 00
        • Aktiv, ikke rekrutterende
        • University Hospital of Ioannina
    • Central District
      • Petah Tikva, Central District, Israel, 4910021
        • Rekruttering
        • Rabin Medical Center
      • Ramat Gan, Central District, Israel, 5265601
        • Rekruttering
        • Sheba Medical Center
    • Jerusalem
      • Jerusalem, Jerusalem, Israel, 9112001
        • Rekruttering
        • Hadassah Medical Center
    • Southern District
      • Beersheba, Southern District, Israel, 8410101
        • Rekruttering
        • Soroka Medical Center
    • TELL ABĪB
      • Tel Aviv, TELL ABĪB, Israel, 6423906
        • Rekruttering
        • Sourasky Medical Center
      • Bologna, Italia, 40138
        • Aktiv, ikke rekrutterende
        • IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola
      • Meldola (FC), Italia, 47014
        • Aktiv, ikke rekrutterende
        • IRCCS - Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori"
      • Milan, Italia, 20141
        • Aktiv, ikke rekrutterende
        • Istituto Europeo di Oncologia IRCCS
      • Milan, Italia, 20142
        • Rekruttering
        • ASST Santi Paolo e Carlo Ospedale San Paolo
      • Pescara, Italia, 65124
        • Rekruttering
        • Ospedale Civile dello Spirito Santo
    • Lombardy
      • Milan, Lombardy, Italia, 20153
        • Rekruttering
        • P.O. San Carlo Borromeo- ASST SANTI PAOLO E CARLO
    • Milano
      • Legnano, Milano, Italia, 20025
        • Aktiv, ikke rekrutterende
        • Azienda Socio Sanitaria Ovest milanese
    • Piedmont
      • Turin, Piedmont, Italia, 10126
        • Aktiv, ikke rekrutterende
        • Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino
    • Sicily
      • Palermo, Sicily, Italia, 90127
        • Aktiv, ikke rekrutterende
        • A.O.U. Policlinico Paolo Giaccone
    • The Marches
      • Ancona, The Marches, Italia, 60126
        • Rekruttering
        • Azienda Ospedaliero Universitaria delle Marche
    • Tuscany
      • Florence, Tuscany, Italia, 50134
        • Aktiv, ikke rekrutterende
        • Azienda Ospedaliera Universitaria Careggi
      • Pisa, Tuscany, Italia, 56126
        • Aktiv, ikke rekrutterende
        • Azienda Ospedaliero Universitaria Pisana
      • Kagoshima, Japan, 890-8520
        • Rekruttering
        • Kagoshima University Hospital
      • Kyoto, Japan, 602-8566
        • Rekruttering
        • University Hospital,Kyoto Prefectural University of Medicine
      • Okayama, Japan, 701-1192
        • Rekruttering
        • National Hospital Organization Okayama Medical Center
      • Yamagata, Japan, 990-9585
        • Rekruttering
        • Yamagata University Hospital
    • Aichi-ken
      • Toyohashi, Aichi-ken, Japan, 441-8570
        • Rekruttering
        • Toyohashi Municipal Hospital
    • Ehime
      • Matsuyama, Ehime, Japan, 790-0024
        • Rekruttering
        • Ehime Prefectural Central Hospital
    • Gunma
      • Maebashi, Gunma, Japan, 371-8511
        • Rekruttering
        • Gunma University Hospital
      • Shibukawa, Gunma, Japan, 377-0280
        • Rekruttering
        • National Hospital Organization Shibukawa Medical Center
    • Hyōgo
      • Kobe, Hyōgo, Japan, 650-0047
        • Rekruttering
        • Kobe City Medical Center General Hospital
    • Iwate
      • Shiwa-gun Yahaba-cho, Iwate, Japan, 028-3695
        • Rekruttering
        • Iwate Medical University Hospital
    • Tokyo
      • Bunkyo-ku, Tokyo, Japan, 113-8603
        • Rekruttering
        • Nippon Medical School Hospital
      • Koto, Tokyo, Japan, 135-8550
        • Rekruttering
        • The Cancer Institute Hospital of JFCR
      • Koto, Tokyo, Japan, 135-8550
        • Rekruttering
        • Japanese Foundation for Cancer Research
    • Yamanashi
      • Kofu, Yamanashi, Japan, 400-8506
        • Rekruttering
        • Yamanashi Prefectural Central Hospital
      • Osijek, Kroatia, 31000
        • Rekruttering
        • Klinicki bolnicki centar Osijek
      • Rijeka, Kroatia, 51000
        • Rekruttering
        • Klinicki bolnicki centar Rijeka
      • Split, Kroatia, 21 000
        • Rekruttering
        • Klinicki bolnicki centar Split
      • Zagreb, Kroatia, 10000
        • Rekruttering
        • Klinicka bolnica Dubrava
      • Zagreb, Kroatia, 10 000
        • Rekruttering
        • University Hospital Center Zagreb
      • Zagreb, Kroatia, 10 000
        • Rekruttering
        • Sestre milosrdnice University Hospital Center
      • Zagreb, Kroatia, 10000
        • Aktiv, ikke rekrutterende
        • Klinicka bolnica Merkur
    • Limburg
      • Maastricht, Limburg, Nederland, 6229 HX
        • Aktiv, ikke rekrutterende
        • Maastricht UMC+
    • South Holland
      • Dordrecht, South Holland, Nederland, 3318 AT
        • Aktiv, ikke rekrutterende
        • Albert Schweitzer Ziekenhuis, locatie Dordwijk
      • Rotterdam, South Holland, Nederland, 3015 GD
        • Aktiv, ikke rekrutterende
        • Erasmus Medisch Centrum
      • Oslo, Norge, 0450
        • Rekruttering
        • Oslo Universitetssykehus Ullevål
    • Akershus
      • Lørenskog, Akershus, Norge, 1478
        • Rekruttering
        • Akershus Universitetssykehus
    • Sør-trøndelag
      • Trondheim, Sør-trøndelag, Norge, 7030
        • Rekruttering
        • St. Olavs Hospital
    • Vestfold
      • Tønsberg, Vestfold, Norge, 3103
        • Rekruttering
        • Sykehuset i Vestfold
      • Braga, Portugal, 4710-243
        • Aktiv, ikke rekrutterende
        • 2Ca Braga
    • Lisbon District
      • Lisbon, Lisbon District, Portugal, 1099-023
        • Aktiv, ikke rekrutterende
        • Instituto Português de Oncologia de Lisboa Francisco Gentil
      • Bratislava, Slovakia, 833 10
        • Aktiv, ikke rekrutterende
        • Narodny onkologicky ustav
      • Bratislava, Slovakia, 851 07
        • Aktiv, ikke rekrutterende
        • Univerzitna nemocnica Bratislava, Nemocnica sv. Cyrila a Metoda
    • Banská Bystrica Region
      • Banská Bystrica, Banská Bystrica Region, Slovakia, 97517
        • Aktiv, ikke rekrutterende
        • Fakultna nemocnica s poliklinikou F.D.Roosevelta Banska Bystrica
    • Košice Region
      • Košice, Košice Region, Slovakia, 040 11
        • Aktiv, ikke rekrutterende
        • Univerzitna Nemocnica L. Pasteura Kosice
      • Ljubljana, Slovenia, 1000
        • Rekruttering
        • University Medical Centre Ljubljana
      • Madrid, Spania, 28050
        • Aktiv, ikke rekrutterende
        • Hospital Universitario HM Sanchinarro
      • Madrid, Spania, 28007
        • Aktiv, ikke rekrutterende
        • Hospital General Universitario Gregorio Marañon
      • Málaga, Spania, 29010
        • Aktiv, ikke rekrutterende
        • H.R.U Málaga - Hospital General
      • Salamanca, Spania, 37007
        • Aktiv, ikke rekrutterende
        • Hospital Universitario de Salamanca - Complejo Asistencial Universitario de Salamanca
      • Valencia, Spania, 46026
        • Aktiv, ikke rekrutterende
        • Hospital Universitari i Politecnic La Fe
    • Barcelona [barcelona]
      • Badalona, Barcelona [barcelona], Spania, 08916
        • Aktiv, ikke rekrutterende
        • Institut Català d'Oncologia (ICO) - Badalona
      • Terrassa, Barcelona [barcelona], Spania, 08221
        • Aktiv, ikke rekrutterende
        • Hospital Universitari Mutua Terrassa
    • Basque Country
      • Barakaldo, Basque Country, Spania, 48903
        • Aktiv, ikke rekrutterende
        • OSI Ezkerraldea-Enkarterri-Cruces - Hospital Universitario Cruces
    • Catalunya [cataluña]
      • Barcelona, Catalunya [cataluña], Spania, 08036
        • Aktiv, ikke rekrutterende
        • Hospital Clínic de Barcelona
    • Galicia [galicia]
      • Murcia, Galicia [galicia], Spania, 30008
        • Aktiv, ikke rekrutterende
        • Hospital General Universitario Morales Meseguer
    • Girona [gerona]
      • Girona, Girona [gerona], Spania, 17007
        • Aktiv, ikke rekrutterende
        • Institut Català d'Oncologia (ICO) - Girona
    • Valenciana, Comunitat
      • Valencia, Valenciana, Comunitat, Spania, 46004
        • Aktiv, ikke rekrutterende
        • ASCIRES ECG Médica S.L
      • Canterbury, Storbritannia, CT1 3NG
        • Rekruttering
        • Kent and Canterbury Hospital
      • Wolverhampton, Storbritannia, WV10 0QP
        • Rekruttering
        • New Cross Hospital
    • Buckinghamshire
      • Milton Keynes, Buckinghamshire, Storbritannia, MK6 5LD
        • Rekruttering
        • Milton Keynes Hospital
    • Denbighshire [SIR Ddinbych Gb-ddb]
      • Bodelwyddan, Denbighshire [SIR Ddinbych Gb-ddb], Storbritannia, LL18 5UJ
        • Rekruttering
        • Glan Clwyd Hospital
    • Dorset
      • Bournemouth, Dorset, Storbritannia, BH7 7DW
        • Rekruttering
        • Royal Bournemouth Hospital
      • Poole, Dorset, Storbritannia, BH15 2JB
        • Rekruttering
        • Poole Hospital
    • EAST Sussex
      • Eastbourne, EAST Sussex, Storbritannia, BN21 2UD
        • Rekruttering
        • Eastbourne District General Hospital
      • Worthing, EAST Sussex, Storbritannia, BN11 2DH
        • Rekruttering
        • Worthing Hospital
    • England
      • Birmingham, England, Storbritannia, B15 2TH
        • Rekruttering
        • Queen Elizabeth Hospital Birmingham
    • Greater London
      • London, Greater London, Storbritannia, E1 1BB
        • Rekruttering
        • Barts Health NHS Trust
    • Gwynedd
      • Bangor, Gwynedd, Storbritannia, LL57 2PW
        • Rekruttering
        • Betsi Cadwaladr University Health Board
    • KENT
      • Maidstone, KENT, Storbritannia, ME16 9QQ
        • Avsluttet
        • Maidstone Hospital
    • London, CITY of
      • London, London, CITY of, Storbritannia, EC1A 7BE
        • Rekruttering
        • St Bartholomew's Hospital
      • London, London, CITY of, Storbritannia, SE1 9RT
        • Rekruttering
        • Guy's & St Thomas' NHS Foundation Trust
      • London, London, CITY of, Storbritannia, SE5 9RL
        • Rekruttering
        • King's College Hospital
    • Oxfordshire
      • Oxford, Oxfordshire, Storbritannia, OX3 7LE
        • Rekruttering
        • Churchill Hospital
    • Staffordshire
      • Stoke-on-Trent, Staffordshire, Storbritannia, ST4 6QG
        • Rekruttering
        • Royal Stoke University Hospital
    • Sutton
      • London, Sutton, Storbritannia, SM2 5PT
        • Rekruttering
        • Royal Marsden Hospital (Sutton)
      • Falun, Sverige, 791 31
        • Aktiv, ikke rekrutterende
        • Falu Lasarett
    • Örebro LÄN [se-18]
      • Örebro, Örebro LÄN [se-18], Sverige, 701 85
        • Aktiv, ikke rekrutterende
        • Universitetssjukhuset Örebro
    • Seoul-teukbyeolsi [seoul]
      • Seoul, Seoul-teukbyeolsi [seoul], Sør -Korea, 03080
        • Rekruttering
        • Seoul National University Hospital
      • Seoul, Seoul-teukbyeolsi [seoul], Sør -Korea, 06351
        • Rekruttering
        • Samsung Medical Center
      • Seoul, Seoul-teukbyeolsi [seoul], Sør -Korea, 03722
        • Rekruttering
        • Severance Hospital, Yonsei University Health System
      • Taichung, Taiwan, 407
        • Rekruttering
        • Taichung Veterans General Hospital
      • Taichung, Taiwan, 404332
        • Rekruttering
        • China Medical University Hospital
    • Brno-město
      • Brno, Brno-město, Tsjekkia, 625 00
        • Rekruttering
        • Fakultní nemocnice Brno Bohunice
    • Praha 10
      • Prague, Praha 10, Tsjekkia, 100 34
        • Rekruttering
        • Fakultni nemocnice Kralovske Vinohrady
      • Berlin, Tyskland, 10249
        • Avsluttet
        • Vivantes Klinikum Am Urban
      • Berlin, Tyskland, 10967
        • Avsluttet
        • Vivantes Klinikum Am Urban
      • Cottbus, Tyskland, 03048
        • Rekruttering
        • Medizinische Universität Lausitz - Carl Thiem
      • Hamm, Tyskland, 59073
        • Rekruttering
        • St. Barbara-Klinik Hamm-Heessen
    • Baden-Wurttemberg
      • Freiburg im Breisgau, Baden-Wurttemberg, Tyskland, 79106
        • Rekruttering
        • Universitaetsklinikum Freiburg
      • Stuttgart, Baden-Wurttemberg, Tyskland, 70376
        • Rekruttering
        • Robert Bosch Krankenhaus GmbH
      • Ulm, Baden-Wurttemberg, Tyskland, 89081
        • Rekruttering
        • Universitaetsklinikum Ulm
    • Bavaria
      • Nuremberg, Bavaria, Tyskland, 90419
        • Rekruttering
        • Klinikum Nürnberg Nord
    • North Rhine-Westphalia
      • Bonn, North Rhine-Westphalia, Tyskland, 53127
        • Rekruttering
        • Universitätsklinikum Bonn

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • Prior diagnosis of multiple myeloma as defined by International Myeloma Working Group (IMWG) criteria and previously received 1 to 4 prior lines of therapy including prior anti-cluster of differentiation 38 (CD38) antibody and prior lenalidomide.
  • Documented evidence of progressive disease or failure to achieve a response to last line of therapy per IMWG criteria.
  • Measurable disease defined as at least 1 of the following: (a) Serum M-protein ≥0.5 g/dL; (b) Urinary M-protein excretion ≥200 mg/24 hours; (c) Serum involved immunoglobulin FLC ≥10 mg/dL AND abnormal serum immunoglobulin kappa to lambda FLC ratio (<0.26 or >1.65).
  • Have clinical laboratory values within the specified range.
  • ECOG (Eastern Cooperative Oncology Group) performance status ≤2.
  • Not pregnant or breastfeeding and willing to use contraception.

Exclusion Criteria:

  • Smoldering multiple myeloma.
  • Plasma cell leukemia.
  • Amyloidosis.
  • Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin abnormalities (POEMS) syndrome.
  • Known central nervous system (CNS) involvement or clinical signs of myelomatous meningeal involvement.
  • Stem cell transplant within 12 weeks prior to enrolment, or active graft versus host disease.
  • Any active, uncontrolled bacterial, fungal, or viral infection.
  • Any other active malignancy within 3 years prior to enrolment (exceptions include, adequately treated basal cell or squamous cell skin cancer, carcinoma in situ)
  • Previous treatment with a B cell maturation antigen (BCMA)-directed therapy or CD3-redirecting therapy.
  • Unable to receive investigator's choice therapy.
  • Live attenuated vaccine within 4 weeks of the first dose of study intervention.
  • Administration with an investigational product (e.g. drug or vaccine) within 30 days preceding the first dose of study intervention used in this study.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Elranatamab

Participants will receive elranatamab monotherapy

Elranatamab will be administered subcutaneously

Aktiv komparator: Investigator's Choice

Participants will receive either Elotuzumab, Pomalidomide and Dexamethasone (EPd), or Pomalidomide, Bortezomib and Dexamethasone (PVd), or Carfilzomib and Dexamethasone (Kd)

Elotuzumab will be administered intravenously

Pomalidomide will be administered orally

Dexamethasone will be administered orally

Bortezomib will be administered subcutaneously or intravenously

Carfilzomib will be administered intravenously

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Progression free survival per International Myeloma Working Group criteria
Tidsramme: Up to approximately 5 years

From date of randomization to date of progressive disease, discontinuation from study, death, or censoring, whichever occurs first

Up to approximately 5 years

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Hyppighet av behandlingsutløste bivirkninger
Tidsramme: Fra datoen for første dose av studieintervensjon inntil 90 dager etter siste studieintervensjonsadministrering
Fra datoen for første dose av studieintervensjon inntil 90 dager etter siste studieintervensjonsadministrering
Hyppighet av unormale laboratorieresultater
Tidsramme: Fra datoen for første dose av studieintervensjon inntil 90 dager etter siste studieintervensjonsadministrering
Fra datoen for første dose av studieintervensjon inntil 90 dager etter siste studieintervensjonsadministrering
Lav konsentrasjon av fritt elranatamab serum [Ctrough]
Tidsramme: Fra datoen for første dose av elranatamab opp til ca. 14 dager etter siste dose av elranatamab
Fra datoen for første dose av elranatamab opp til ca. 14 dager etter siste dose av elranatamab
Elranatamab immunogenisitet av anti-legemiddel antistoffer mot elranatamab
Tidsramme: Fra datoen for første dose av elranatamab opp til ca. 14 dager etter siste dose av elranatamab
Fra datoen for første dose av elranatamab opp til ca. 14 dager etter siste dose av elranatamab
Overall survival
Tidsramme: Up to approximately 5 years

From date of randomization to date of discontinuation from study, death, or censoring, whichever occurs first

Up to approximately 5 years
Progression free survival on next-line treatment per International Myeloma Working Group criteria
Tidsramme: Up to approximately 5 years

From date of randomization to date of second objective disease progression, discontinuation from the study, death, or censoring, whichever occurs first

Up to approximately 5 years
Objective response rate per International Myeloma Working Group criteria
Tidsramme: Up to approximately 5 years

From date of randomization to date of progressive disease, discontinuation from study, death, or start of new anticancer therapy

Up to approximately 5 years
Duration of response per International Myeloma Working Group criteria
Tidsramme: Up to approximately 5 years

From date of confirmed objective response to date of progressive disease, discontinuation from study, death, or censoring, whichever occurs first

Up to approximately 5 years
Very good partial response or better response rate per International Myeloma Working Group criteria
Tidsramme: Up to approximately 5 years

From date of randomization to date of progressive disease, discontinuation from study, death, or start of new anticancer therapy, whichever occurs first

Up to approximately 5 years
Complete response rate per International Myeloma Working Group criteria
Tidsramme: Up to approximately 5 years

From date of randomization to date of progressive disease, discontinuation from study, death, or start of new anticancer therapy, whichever occurs first

Up to approximately 5 years
Duration of complete response per International Myeloma Working Group criteria
Tidsramme: Up to approximately 5 years

From date of confirmed complete response to date of progressive disease, discontinuation from study, death, or censoring, whichever occurs first

Up to approximately 5 years
Time to response per International Myeloma Working Group criteria
Tidsramme: Up to approximately 5 years

From date of randomization to date of confirmed objective response

Up to approximately 5 years
Minimal residual disease negativity rate per International Myeloma Working Group criteria
Tidsramme: Up to approximately 5 years

From date of randomization to date of progressive disease, discontinuation from study, death, or start of new anticancer therapy, whichever occurs first

Up to approximately 5 years
Sustained minimal residual disease negativity rate per International Myeloma Working Group criteria
Tidsramme: Up to approximately 5 years

From date of randomization to date of progressive disease, discontinuation from study, death, or start of new anticancer therapy, whichever occurs first

Up to approximately 5 years
Duration of minimal residual disease negativity rate per International Myeloma Working Group criteria
Tidsramme: Up to approximately 5 years

From date of minimal residual disease negativity to date of relapse, death, or censoring, whichever occurs first

Up to approximately 5 years
Health-related quality of life by European Organization for Research and Treatment of Cancer Quality of Life Questionnaire - Core 30
Tidsramme: From date of informed consent up to approximately 35 days after last administration of study intervention

Change from baseline scores

From date of informed consent up to approximately 35 days after last administration of study intervention
Health-related quality of life by European Organization for Research and Treatment of Cancer Quality of Life Questionnaire - Myeloma 20
Tidsramme: From date of informed consent up to approximately 35 days after last administration of study intervention

Change from baseline scores

From date of informed consent up to approximately 35 days after last administration of study intervention

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Etterforskere

  • Studieleder: Pfizer CT.gov Call Center, Pfizer

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

8. februar 2024

Primær fullføring (Faktiske)

26. august 2026

Studiet fullført (Antatt)

30. desember 2027

Datoer for studieregistrering

Først innsendt

17. november 2023

Først innsendt som oppfylte QC-kriteriene

28. november 2023

Først lagt ut (Faktiske)

30. november 2023

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

12. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

10. november 2026

Sist bekreftet

1. november 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

JA

IPD-planbeskrivelse

Pfizer will provide access to individual de-identified participant data and related study documents (e.g. protocol, Statistical Analysis Plan (SAP), Clinical Study Report (CSR)) upon request from qualified researchers, and subject to certain criteria, conditions, and exceptions. Further details on Pfizer's data sharing criteria and process for requesting access can be found at: https://www.pfizer.com/science/clinical_trials/trial_data_and_results/data_requests.

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Ja

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .